Sharing information of diagnosis and treatment decisions reassured women newly diagnosed with breast cancer of their health choices, according to a new study published in JAMA Oncology.
A new study has found that combining ipilimumab with local peripheral treatments such as radiotherapy or electrochemotherapy can significantly better survival in patients with melanoma.
Michael Kolodziej, MD, explains the rationale for health plan coverage of biomarker diagnostic tests, and the importance of early identification of responders versus nonresponders.
Antoni Ribas, MD, PhD, provides insight on immuno-oncology as it pertains to modern-day treatment of solid tumors and hematologic malignancies, his expectations regarding immunotherapy toxicities, and the status of PD-L1 as a biomarker.
Benjamin P. Levy, MD, highlights the use of immunotherapy for lung cancer treatment and expectations regarding its toxicities versus standard chemotherapy.


May 15-19, 2015
New Orleans, LA
May 29-June 2, 2015
Chicago, IL
June 11-14, 2015
Vienna, Austria
June 17-20, 2015
Lugano, Switzerland
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium